fml-neo liquifilm 1/5 mg/ml eye drops suspension
allergan pharmaceuticals ireland - neomycin sulfate fluorometholone - eye drops suspension - 1/5 mg/ml
genoptic liquifilm 0.30 %w/v eye drops solution
allergan pharmaceuticals ireland - gentamicin sulfate - eye drops solution - 0.30 %w/v
liquifilm tears ocular lubricant 1.4 %w/v eye drops solution
allergan pharmaceuticals ireland - polyvinyl alcohol - eye drops solution - 1.4 %w/v
oxylin liquifilm 0.025% w/v eye drops, solution 0.025 %w/v eye drops solution
allergan pharmaceuticals ireland - oxymetazoline hydrochloride - eye drops solution - 0.025 %w/v
preferin - a topical ophthalmic 0.12; 0.1 %w/v eye drops solution
allergan pharmaceuticals ireland - mepyramine maleate phenylephrine hydrochloride - eye drops solution - 0.12; 0.1 %w/v
propine sterile ophthalmic 0.1 %w/v eye drops solution
allergan pharmaceuticals ireland - dipivefrine hydrochloride - eye drops solution - 0.1 %w/v
zorac 0.05 %w/w gel
allergan pharmaceuticals ireland - tazarotene - gel - 0.05 %w/w
zorac 0.1 %w/w gel
allergan pharmaceuticals ireland - tazarotene - gel - 0.1 %w/w
ozurdex 700microgram intravitreal implant in applicator
allergan ltd - dexamethasone - implant - 700microgram
ozurdex
abbvie biopharmaceuticals ltd, israel - dexamethasone - implant in applicator - dexamethasone 0.7 mg - dexamethasone - dexamethasone - ozurdex is indicated for the treatment of adult patients with:• diabetic macular oedema (dme)• macular oedema following either branch retinal vein occlusion (brvo) or central retinal vein occlusion (crvo).• inflammation of the posterior segment of the eye presenting as non-infectious uveitis.